Hepatitis B Diagnostic Test Market Segments and Key Trends 2016-2026
Future Market Insights has announced the addition of the “Hepatitis B Diagnostic Test Market: Global Industry Analysis and Opportunity Assessment 2016-2026” report to their offering.
Future Market Insights has announced the addition of the “Hepatitis B Diagnostic Test Market: Global Industry Analysis and Opportunity Assessment 2016-2026” report to their offering.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Global <strong>Hepatitis</strong> B<br />
<strong>Diagnostic</strong> <strong>Test</strong><br />
<strong>Market</strong><br />
Share, Global <strong>Trends</strong>,<br />
Analysis, Research, Report,<br />
Opportunities,<br />
Segmentation <strong>and</strong> Forecast,<br />
<strong>2016</strong>-<strong>2026</strong><br />
Future <strong>Market</strong> Insights<br />
www.futuremarketinsights.com<br />
sales@futuremarketinsights.com
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom research reports, <strong>and</strong> consulting<br />
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,<br />
technology inputs, valuable growth insights, aerial view of the competitive framework, <strong>and</strong> future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, <strong>and</strong> BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, <strong>and</strong><br />
Retail.<br />
We have a global presence with delivery centers across India specializing in providing global research reports <strong>and</strong> country<br />
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.<br />
We combine our knowledge <strong>and</strong> learning from every corner of the world to distill it to one thing – the perfect solution for<br />
our client.<br />
Research Capabilities<br />
• Customized Research<br />
• Syndicated Research<br />
• Investment Research<br />
• Social Media Research<br />
Sector Coverage<br />
• Automotive <strong>and</strong> Transportation<br />
• Electronics, Semiconductor, <strong>and</strong> ICT<br />
• Retail <strong>and</strong> Consumer Products<br />
• Industrial Automation <strong>and</strong> Equipment<br />
• Chemicals & Materials<br />
• Food <strong>and</strong> Beverages<br />
• Services <strong>and</strong> Utilities<br />
• Energy, Mining, Oil, <strong>and</strong> Gas<br />
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Information<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com
Report Description<br />
<strong>Hepatitis</strong> B is an infectious disease associated with the inflammation of the liver. <strong>Hepatitis</strong> B<br />
infection is caused due to the <strong>Hepatitis</strong> B virus (HBV) transmitted from one person to other<br />
through infectious blood, semen <strong>and</strong> other body fluids. <strong>Hepatitis</strong> B infection can be acute <strong>and</strong> it<br />
may develop into chronic infection if not diagnosed <strong>and</strong> treated at an early stage. Chronically<br />
infected <strong>Hepatitis</strong> B patients eventually develop liver cirrhosis, hepatocellular carcinoma (liver<br />
cancer), fulminant hepatitis B (autoimmune disorder) or suffer from liver failure requiring liver<br />
transplant <strong>and</strong> can even result in death. In 2014, out of the 360 Mn people infected with<br />
hepatitis B worldwide, around 1 Mn people died of the disease or other complications<br />
associated with it. However, there is a significant decrease in incidence of hepatitis B after<br />
introduction of hepatitis B vaccine. Diagnosis of HBV is achieved by performing several tests for<br />
serological markers of HBV such as HBsAg, anti-HBs antibodies, HBeAg, anti-HBe antibodies <strong>and</strong><br />
anti-HBV core antibodies. Currently, nucleic acid testing for HBV DNA is used to detect the<br />
hepatitis B viral load. The diagnosis of hepatitis B involves collection of blood samples followed<br />
by the detection of viral antigens <strong>and</strong> antibodies in either serum or plasma.<br />
<strong>Hepatitis</strong> B <strong>Diagnostic</strong> <strong>Test</strong> <strong>Market</strong>: Drivers <strong>and</strong> Restraints<br />
In vitro diagnostics is the vital market for the hepatitis B diagnostic test as the serological<br />
markers from blood are tested outside the body in the laboratory. Increasing prevalence <strong>and</strong><br />
incidence of hepatitis B worldwide <strong>and</strong> multitude of available tests are the major drivers for the<br />
increasing growth of global hepatitis B diagnostic test market.
Increasing public awareness <strong>and</strong> underst<strong>and</strong>ing of viral hepatitis, promotion of wider access to<br />
monitoring <strong>and</strong> screening procedures by several countries as a part of national program <strong>and</strong><br />
introduction of evidence based policies are anticipated to aid the growth of global hepatitis B<br />
diagnostic tests market. However, complexity of clinical management <strong>and</strong> lack of coordination<br />
between clinicians <strong>and</strong> laboratory personnel to decide choice of assay employing appropriate<br />
hepatitis B diagnostic test will remain some of the major restraints for the global hepatitis B<br />
diagnostic test market.<br />
Request for sample report: http://www.futuremarketinsights.com/reports/sample/rep-gb-1332<br />
<strong>Hepatitis</strong> B <strong>Diagnostic</strong> <strong>Test</strong> <strong>Market</strong>: Segmentation<br />
The global hepatitis B diagnostic tests market is classified on the basis of test type, technique<br />
end use <strong>and</strong> geography.<br />
Based on test type, the global hepatitis B diagnostic test market is segmented into the following:<br />
<strong>Hepatitis</strong> B surface antigen test (HBsAg)<br />
Anti-hepatitis B surface antibody test<br />
<strong>Hepatitis</strong> B core antigen test (HBcAb)<br />
Anti-hepatitis B core antibody test<br />
HBV DNA test<br />
Others<br />
Report Description
Based on techniques, the global hepatitis B diagnostic test market is segmented into the<br />
following:<br />
PCR<br />
Report Description<br />
Radioimmunoassay (RIA)<br />
Enzyme-linked immunosorbent assay (ELISA)<br />
Others<br />
Based on end use type, the global hepatitis B diagnostic test market is segmented into the<br />
following:<br />
Hospitals<br />
<strong>Diagnostic</strong> centers<br />
Clinics<br />
<strong>Hepatitis</strong> B <strong>Diagnostic</strong> <strong>Test</strong> <strong>Market</strong>: Overview<br />
More than 13 immunoassays are available for the diagnosis of hepatitis B at an early stage.<br />
They can also be used to distinguish acute <strong>and</strong> chronic hepatitis B infections. Global market<br />
for HBsAg test is expected to drive the greater revenue generation as it the preliminary test<br />
for the detection of HBV in the blood of infected person <strong>and</strong> also the test is ordered for<br />
many of the blood donors prior to blood donation.
Report Description<br />
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1332<br />
<strong>Hepatitis</strong> B <strong>Diagnostic</strong> <strong>Test</strong> <strong>Market</strong>: Regional Overview<br />
Geographically, the global hepatitis B diagnostic tests market is classified into regions<br />
namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan,<br />
Middle East <strong>and</strong> Africa. North America is expected to be the key region in global hepatitis<br />
diagnostic tests market followed by Asia-Pacific <strong>and</strong> Europe. Availability of good<br />
reimbursement policies for diagnostic tests in many of the high income countries in Europe<br />
is expected to keep up the market for hepatitis B diagnostic testsin nearest future.<br />
<strong>Hepatitis</strong> B <strong>Diagnostic</strong> <strong>Test</strong> <strong>Market</strong>: <strong>Key</strong> Players<br />
Some of the key players providing diagnostic tests for hepatitis B are MedMira Inc, Abbott<br />
Laboratories, Inovio pharmaceuticals Inc., Siemens Healthcare GmbH, Innovita biological<br />
technology Co. Ltd., Assure Tech. (Hangzhou) Co. Ltd., Nantong Diagnos biotechnology Co.<br />
Ltd., Blue Cross Bio-Medical (Beijing) Co. Ltd., BioGenex., Abnova Corporation etc.
Thank You!<br />
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
Future <strong>Market</strong> Insights: 616 Corporate Way, Suite 2-9018,<br />
Valley Cottage, NY 10989, United States<br />
T: +1-347-918-3531 | D: +1-845-579-5705
Change language